Medicinova, Inc. v. Genzyme Corporation

U.S. Court of Appeals for the Federal Circuit

Medicinova, Inc. v. Genzyme Corporation

Opinion

Case: 20-1064 Document: 70 Page: 1 Filed: 12/14/2020

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

MEDICINOVA, INC., A DELAWARE CORPORATION, Plaintiff-Appellant

v.

GENZYME CORPORATION, A MASSACHUSETTS CORPORATION, Defendant-Appellee ______________________

2020-1064 ______________________

Appeal from the United States District Court for the Southern District of California in No. 3:14-cv-02513-JLS- KSC, Judge Janis L. Sammartino. ______________________

JUDGMENT ______________________

BRUCE G. CHAPMAN, Sheppard, Mullin, Richter & Hampton LLP, Los Angeles, CA, argued for plaintiff-appel- lant. Also represented by DON PELTO, Washington, DC; MATTHEW G. HALGREN, MARK GERARD RACKERS, San Diego, CA.

FRANCIS DIGIOVANNI, Faegre Drinker Biddle & Reath LLP, Wilmington, DE, argued for defendant-appellee. Also Case: 20-1064 Document: 70 Page: 2 Filed: 12/14/2020

represented by MICHAEL CURT LAMBERT, THATCHER A. RAHMEIER; RABIYA KADER, Sanofi, Bridgewater, NJ. ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (DYK, BRYSON, and O’MALLEY, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

December 14, 2020 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Reference

Status
Unpublished